NAFLD, NASH and liver cancer

@article{Michelotti2013NAFLDNA,
  title={NAFLD, NASH and liver cancer},
  author={G. Michelotti and M. Machado and A. Diehl},
  journal={Nature Reviews Gastroenterology &Hepatology},
  year={2013},
  volume={10},
  pages={656-665}
}
  • G. Michelotti, M. Machado, A. Diehl
  • Published 2013
  • Medicine
  • Nature Reviews Gastroenterology &Hepatology
  • NAFLD affects a large proportion of the US population and its incidence and prevalence are increasing to epidemic proportions around the world. As with other liver diseases that cause cirrhosis, NAFLD increases the risk of liver cancer, a disease with poor outcomes and limited therapeutic options. The incidences of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma are also rising, and HCC is now the leading cause of obesity-related cancer deaths in middle-aged men in the USA… CONTINUE READING
    584 Citations

    Figures, Tables, and Topics from this paper.

    Paper Mentions

    INTERVENTIONAL CLINICAL TRIAL
    Nonalcoholic steatohepatitis is a growing public health problem affecting over 5% of the population. These patients are at increased risk of cardiovascular and liver-related death… Expand
    ConditionsNon-Alcoholic Fatty Liver Disease, Obesity
    InterventionBehavioral, Device
    Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC.
    • 10
    NAFLD: a multisystem disease.
    • 899
    • PDF
    A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma
    • 3
    • PDF

    References

    SHOWING 1-10 OF 151 REFERENCES
    Clinical features of nonalcoholic fatty liver disease-associated hepatocellular carcinoma.
    • 49
    Genetic variation in the PNPLA3 gene and hepatocellular carcinoma in USA: Risk and prognosis prediction
    • 58